ahlam1399
07-02-2016, 03:00 AM
BRIEF-Citius Pharmaceuticals discontinues Suprenza to focus on core assets
* Citius Pharmaceuticals discontinues Suprenza to focus on
core assets
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=VoIQQ30P2DM:RN-3gkN-zWI:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=VoIQQ30P2DM:RN-3gkN-zWI:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=VoIQQ30P2DM:RN-3gkN-zWI:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=VoIQQ30P2DM:RN-3gkN-zWI:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=VoIQQ30P2DM:RN-3gkN-zWI:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/VoIQQ30P2DM
* Citius Pharmaceuticals discontinues Suprenza to focus on
core assets
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=VoIQQ30P2DM:RN-3gkN-zWI:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=VoIQQ30P2DM:RN-3gkN-zWI:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=VoIQQ30P2DM:RN-3gkN-zWI:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=VoIQQ30P2DM:RN-3gkN-zWI:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=VoIQQ30P2DM:RN-3gkN-zWI:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/VoIQQ30P2DM